6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Hip fracture risk and safety with alendronate treatment in the oldest-old.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          There is high evidence for secondary prevention of fractures, including hip fracture, with alendronate treatment, but alendronate's efficacy to prevent hip fractures in the oldest-old (≥80 years old), the population with the highest fracture risk, has not been studied.

          Related collections

          Author and article information

          Journal
          J. Intern. Med.
          Journal of internal medicine
          Wiley-Blackwell
          1365-2796
          0954-6820
          Dec 2017
          : 282
          : 6
          Affiliations
          [1 ] Department of Orthopaedic Surgery, Skaraborg Hospital, Skövde, Sweden.
          [2 ] Geriatric Medicine, Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden.
          [3 ] Department of Medicine Huddinge, Karolinska Institute, Stockholm, Sweden.
          [4 ] Institute for Health and Ageing, Catholic University of Australia, Melbourne, Vic., Australia.
          [5 ] School of Bioscience, University of Skövde, Skövde, Sweden.
          [6 ] Geriatric Medicine, Sahlgrenska University Hospital, Mölndal, Sweden.
          Article
          10.1111/joim.12678
          28857352
          80f02415-127a-43f1-ac5e-7bc07ac5b635
          History

          elderly,fracture,osteoporosis,treatment,alendronate,efficiency
          elderly, fracture, osteoporosis, treatment, alendronate, efficiency

          Comments

          Comment on this article